We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease

News   Jan 17, 2011

 
Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease
 
 
 

RELATED ARTICLES

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

Collaboration Fuels Hunt for New “Orphan Disease” Treatments

News

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs in the hope that some could be adapted to treat orphan diseases.

READ MORE

Harmful Gene Interactions Trigger Rare Form of GI Tumor

News

The "breakdown" of the normal 3D shape of DNA enables harmful interactions to form between genes in a rare type of gastrointestinal stromal tumors.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE